Matinas Biopharma

MTNB

1.14011.63% ( -0.150 )

Closed: Nov 3, 16:00:00 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Matinas Biopharma(MTNB) the EBIT is -1.555 M (+15.35%);the EPS is -3.1 (+79.92%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

EBIT

-0.00B15.35%

----

----

EPS

-3.104879.92%

----

----

Upcoming earnings report - Q3 FY2026

Available dateNov 11, 2026

Estimate Revenue--

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly